Trazodone Dosing for Anxiety
For anxiety disorders, trazodone should be initiated at 25 mg per day and titrated to 200-400 mg per day in divided doses, though evidence for its use specifically for anxiety is limited and it is not FDA-approved for this indication. 1
FDA-Approved Dosing vs. Off-Label Use
The FDA has only approved trazodone for major depressive disorder, not anxiety. The official dosing starts at 150 mg/day in divided doses for depression, with gradual increases of 50 mg every 3-4 days up to 400 mg/day for outpatients (600 mg/day for inpatients). 2
However, clinical practice guidelines and research support lower starting doses for anxiety-related symptoms:
Recommended Dosing Algorithm for Anxiety
Starting Dose
- Begin with 25 mg per day 1
- This lower dose targets sedative and anxiolytic effects without requiring full antidepressant dosing
- Take shortly after a meal or light snack to optimize absorption 2
Titration Schedule
- Increase by 25-50 mg increments every 5-7 days based on tolerability and response 1
- Monitor for therapeutic benefit and adverse effects at each increment
- Most patients with anxiety respond to doses between 50-150 mg/day 3, 4
Target Dose Range
- For anxiety symptoms: 50-150 mg/day typically suffices 3, 4
- For agitation/severe anxiety: 200-400 mg/day in divided doses 1
- Maximum outpatient dose should not exceed 400 mg/day 2
Evidence Quality and Clinical Context
The evidence supporting trazodone for anxiety is moderate but dated. A 1993 placebo-controlled trial showed trazodone (mean dose 255 mg/day) achieved comparable anxiolytic efficacy to diazepam by weeks 3-8, with 69% of completers reporting moderate-to-marked improvement. Psychic symptoms (tension, apprehension, worry) responded better than somatic symptoms. 5
Important caveats:
- Trazodone showed slower onset than benzodiazepines (2-3 weeks vs. immediate) 5
- Higher adverse effect rates than diazepam, though dropout rates were similar 5
- More recent guidelines (2017 AASM) actually recommend against trazodone for insomnia due to weak evidence 6, raising questions about its anxiety indication
Specific Clinical Scenarios
Anxiety with Insomnia
- Start at 25-50 mg at bedtime 7, 8
- This dose provides sedation without full antidepressant effects
- Can increase to 100 mg if needed for sleep maintenance 8
Panic Disorder
- One small trial used 300 mg/day with significant improvement in panic symptoms over 8 weeks 9
- Start low (25-50 mg) and titrate more aggressively to 200-300 mg range
Generalized Anxiety Disorder
- Target dose 200-300 mg/day in divided doses based on the 1993 GAD trial 5
- Expect 2-3 weeks for full anxiolytic effect
Agitation in Dementia/Alzheimer's
- Guidelines recommend 25 mg/day initially, maximum 200-400 mg/day in divided doses 1
- Use with caution in patients with premature ventricular contractions 1
Safety Considerations
Monitor for:
- Orthostatic hypotension (especially in elderly)
- Sedation/drowsiness (may require bedtime dosing)
- Priapism (rare but serious; 5% discontinuation rate in one study) 10
- Serotonin syndrome if combined with other serotonergic agents 2
- QT prolongation with certain drug combinations 11
Dose adjustments needed:
- Reduce dose with strong CYP3A4 inhibitors 2
- Increase dose may be needed with strong CYP3A4 inducers 2
- Taper gradually when discontinuing to avoid withdrawal symptoms 2
Bottom Line
While trazodone can be effective for anxiety at doses of 200-300 mg/day, first-line treatments for anxiety disorders remain SSRIs, SNRIs, or benzodiazepines depending on the specific disorder. Trazodone is best reserved for patients with comorbid insomnia and anxiety, those who have failed first-line treatments, or when sexual dysfunction from SSRIs is a concern. The evidence base is limited and dated, requiring clinical judgment in its application.